https://www.womansera.com/timeline-of-companies-wo
Post# of 36537
Generex mentioned in the article -
On 27 February 2020, a Generex subsidiary company, NuGenerex Immuno-Oncology announces they were beginning a vaccine project to create an Ii-Key peptide vaccine against COVID-19. They wanted to produce a vaccine candidate that could be tested in humans “within 90 days.”